Neurology Minute

In Part 2 of a 3-part series, Karin G. Johnson, MD, FAAN, FAASM, discusses her article, "Obstructive Sleep Apnea" from the August Continuum Sleep Neurology issue. This article and accompanying Continuum Audio interview are available to all at continpub.com/

In Part 1 of a 3-part series, Karin G. Johnson, MD, FAAN, FAASM, discusses her article, "Obstructive Sleep Apnea" from the August Continuum Sleep Neurology issue. This article and accompanying Continuum Audio interview are available to all at continpub.com/      

Prof. Jon Stone talks with Drs. Selma Aybek about how and why FND occurs. Show references: https://directory.libsyn.com/episode/index/id/27868815

Dr.  Geoffrey A. Donnan discusses his paper, "Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People". Show references: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2807630

Dr. Tesha Monteith talks with Dr. Wouter Schievink about what spontaneous intracranial hypotension is and why it's commonly misdiagnosed. Full podcast: https://directory.libsyn.com/episode/index/id/27833880

Dr. Jason Crowell talks with Dr. Frederic Schaper about legion-related epilepsy mapping to a specific brain network.  Show references: https://jamanetwork.com/journals/jamaneurology/fullarticle/2806404 Full podcast: https://directory.libsyn.com/episode/index/id/27809031

Dr. Rachel Marie E. Salas discusses REM sleep disorders. Show references: https://www.aan.com/education/neuropanels

Dr. Halley Alexander discusses the Neurology Today article, "The FDA and CMS Have Pressed the Go Button on Lecanemab. What Happens Now?" Show References: https://journals.lww.com/neurotodayonline/fulltext/2023/08170/the_fda_and_cms_have_pressed_the_go_button_on.1.aspx https://neurology.libsyn.com/website/lecanemab-in-early-alzheimers-disease

Dr. Gordon Smith talks with Dr. Ajay Sampat about his journey of being a neurologist and getting diagnosed with ALS at 36.

In the third episode of a four-part series on autoimmune encephalitis, Dr. Justin Abbatemarco talks with Drs. Eoin Flanagan and Grace Gombolay about a practical approach to testing for auto antibodies and autoimmune encephalitis. Listen to the full podcast here: https://directory.libsyn.com/episode/index/id/27747390

In part 3 of a 3-part series, Dr. Rogan Magee discusses using handwriting and drawing to help evaluate patients with movement disorders.      

In part 2 of a 3-part series, Dr. Rogan Magee discusses using handwriting and drawing to help evaluate patients with movement disorders.      

In part 1 of a 3-part series, Dr. Rogan Magee discusses using handwriting and drawing to help evaluate patients with movement disorders.

In the second episode of a four-part series on autoimmune encephalitis, Dr. Justin Abbatemarco talks with Drs. Sarosh Irani and John Soltys about a practical approach to testing for auto antibodies and autoimmune encephalitis. Listen to the full conversation here: https://directory.libsyn.com/episode/index/id/27712707

In the first episode of a four-part series on autoimmune encephalitis, Dr. Justin Abbatemarco talks with Dr. Josep Dalmau about relevant updates on autoimmune encephalitis, ongoing/upcoming clinical trials, and so much more. Show references: https://directory.libsyn.com/episode/index/id/27682701

Dr. Tanu Garg discusses the diagnosis of carotid web.

In part 2 of a 2-part series, Dr. Halley Alexander explores the potential benefits and risks involved for individuals with epilepsy who desire to actively engage in sports or exercise activities.      

In part 1 of a 2-part series, Dr. Halley Alexander explores the potential benefits and risks involved for individuals with epilepsy who desire to actively engage in sports or exercise activities.

Dr. David Perez discusses the diagnosis of FND and new phenotypes. This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.

Dr. Natalia Rost discusses her testimony to Congress on New Alzheimer’s Treatments. Show references: This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.